- NERV Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Minerva Neurosciences (NERV) CORRESPCorrespondence with SEC
Filed: 22 Aug 18, 12:00am
August 22, 2018
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Re: | Minerva Neurosciences, Inc. |
Registration Statement on FormS-3 (FileNo. 333-226783) |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on FormS-3 to become effective at 4:00 p.m. Eastern Time on August 24, 2018 or as soon thereafter as is practicable.
Sincerely, | ||
MINERVA NEUROSCIENCES, INC. | ||
By: | /s/ Devin Smith | |
Name: Devin Smith | ||
Title: General Counsel | ||
cc: | Marc A. Recht, Esq. Ryan S. Sansom, Esq. |